It appears that Trulieve Cannabis (CSE: TRUL) is facing a slight public relations issue currently. Earlier today, what appears to be an employee of the company took to Reddit an announcement that there has allegedly been multiple employees at their Florida dispensaries that have tested positive for coronavirus. Allegations made by the poster include that the company has not been forthcoming with telling other employees that they may have had a shift or contact with the affected individuals.
Additional complaints made by the poster include the statement that hazard pay has not been provided for the essential workers, and that a large portion of employees are labeled as part time. The result of which is that benefits are said to be “sparse if available at all.”
Similar sentiment was reinforced by several other posters on the Reddit thread, by both what appears to be employees and patients alike, however employment was not verified. One poster claimed to be an employee at a different location which is claimed to have had positive cases among employees. It’s stated that no facility shutdown occurred after the positive cases were registered, with employees stated as being scared to show up to work and managers walking out.
With respect to patients, there were several complaints in the thread related to the waiting room and the time required to be inside. While the company notably has what appears to be a “text and go” system in place for those who wish to use it, it appears to be heavily flawed in that several commentators reported waiting for times of up to twenty minutes in crowded rooms, despite being alerted that their order was ready.
In the name of balanced reporting however, it appears that issues for customers at the very least appear to be limited to certain stores only, with some commentators identifying no issues in terms of wait times at their local dispensaries.
While none of the claims have been verified individually by The Deep Dive, it seems that the company appears to be going through some pain in relation to the ongoing pandemic, as can be expected to a certain extent. However, many reports indicate that the company appears to remain focused on sales more than that of safety, despite soaring infection rates within the state.
Trulieve Cannabis last traded at $19.50 on the CSE.
Information for this briefing was found via Reddit. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.